{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:08:08Z","timestamp":1791331688914,"version":"4.3.1"},"reference-count":37,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2018,6,9]],"date-time":"2018-06-09T00:00:00Z","timestamp":1528502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Italian Ministry for University and Scientific Research","award":["Fondi Ateneo Linea D-1 2016"],"award-info":[{"award-number":["Fondi Ateneo Linea D-1 2016"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,18]]},"DOI":"10.1093\/cid\/ciy492","type":"journal-article","created":{"date-parts":[[2018,6,6]],"date-time":"2018-06-06T19:10:21Z","timestamp":1528312221000},"page":"355-364","source":"Crossref","is-referenced-by-count":328,"title":["Efficacy of Ceftazidime-Avibactam Salvage Therapy in Patients With Infections Caused by<i>Klebsiella pneumoniae<\/i>Carbapenemase\u2013producing<i>K. pneumoniae<\/i>"],"prefix":"10.1093","volume":"68","author":[{"given":"Mario","family":"Tumbarello","sequence":"first","affiliation":[{"name":"Institute of Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli \u2013 Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)\u2013Universit\u00e0 Cattolica del Sacro Cuore, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico Maria","family":"Trecarichi","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli \u2013 Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)\u2013Universit\u00e0 Cattolica del Sacro Cuore, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Corona","sequence":"additional","affiliation":[{"name":"Intensive Care Unit Department of Emergency, Luigi Sacco Hospital\u2013Azienda Socio Sanitaria Territoriale (ASST)\u2013Fatebenefratelli Sacco, University of Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Giuseppe","family":"De Rosa","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[{"name":"Infectious Disease Division, Santa Maria Misericordia University Hospital, Udine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[{"name":"Clinica delle Malattie Infettive, Universit\u00e0 di Modena e Reggio Emilia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Menichetti","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Cisanello Hospital, Pisa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Viscoli","sequence":"additional","affiliation":[{"name":"Infectious Diseases Division, Universit\u00e0 di Genova e Ospedale Policlinico San Martino IRCCS per l\u2019oncologia e le neuroscienze, Genoa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Campoli","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Medical and Clinical Sciences, S. Orsola-Malpighi Hospital, Alma Mater Studiorum University of Bologna"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Venditti","sequence":"additional","affiliation":[{"name":"Dipartimento di Salute Pubblica e Malattie Infettive, Policlinico Umberto I Universit\u00e0 \u2018Sapienza\u2019, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"De Gasperi","sequence":"additional","affiliation":[{"name":"Anestesia Rianimazione 2\u2013ASST ospedale Niguarda Ca Granda, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Mularoni","sequence":"additional","affiliation":[{"name":"Infectious Diseases Istituto mediterraneo per i trapianti e terapie ad alta specializzazione-IRCCS Palermo"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Tascini","sequence":"additional","affiliation":[{"name":"Prima divisione di Malattie Infettive, Ospedale Cotugno, Azienda Ospedaliera dei Colli, Napoli"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Parruti","sequence":"additional","affiliation":[{"name":"Unit\u00e0 Operativa Complessa Malattie Infettive, Azienda Unit\u00e0 Sanitaria Locale Pescara"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Pallotto","sequence":"additional","affiliation":[{"name":"Infectious Diseases Section, Department of Medicine, University of Perugia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Sica","sequence":"additional","affiliation":[{"name":"Institute of Hematology, Universit\u00e0 Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercole","family":"Concia","sequence":"additional","affiliation":[{"name":"Malattie Infettive, Ospedale Universitario di Verona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Cultrera","sequence":"additional","affiliation":[{"name":"Malattie Infettive, Dipartimento di Scienze Mediche, Universit\u00e0 degli Studi di Ferrara"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"De Pascale","sequence":"additional","affiliation":[{"name":"Department of Intensive Care and Anaesthesiology, Fondazione Policlinico Universitario A. Gemelli IRCCS \u2013 Universit\u00e0 Cattolica del Sacro Cuore, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Capone","sequence":"additional","affiliation":[{"name":"Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani IRCCS Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spinello","family":"Antinori","sequence":"additional","affiliation":[{"name":"Department of Clinical and Biomedical Sciences \u201cL. Sacco,\u201d University of Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Corcione","sequence":"additional","affiliation":[{"name":"Department of Medical Sciences, University of Turin"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elda","family":"Righi","sequence":"additional","affiliation":[{"name":"Infectious Disease Division, Santa Maria Misericordia University Hospital, Udine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Raffaella","family":"Losito","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli \u2013 Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)\u2013Universit\u00e0 Cattolica del Sacro Cuore, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margherita","family":"Digaetano","sequence":"additional","affiliation":[{"name":"Clinica delle Malattie Infettive, Universit\u00e0 di Modena e Reggio Emilia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Amadori","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department, Cisanello Hospital, Pisa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele Roberto","family":"Giacobbe","sequence":"additional","affiliation":[{"name":"Infectious Diseases Division, Universit\u00e0 di Genova e Ospedale Policlinico San Martino IRCCS per l\u2019oncologia e le neuroscienze, Genoa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Ceccarelli","sequence":"additional","affiliation":[{"name":"Dipartimento di Salute Pubblica e Malattie Infettive, Policlinico Umberto I Universit\u00e0 \u2018Sapienza\u2019, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernestina","family":"Mazza","sequence":"additional","affiliation":[{"name":"Anestesia Rianimazione 2\u2013ASST ospedale Niguarda Ca Granda, Milan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Raffaelli","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli \u2013 Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)\u2013Universit\u00e0 Cattolica del Sacro Cuore, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Spanu","sequence":"additional","affiliation":[{"name":"Institute of Microbiology, Fondazione Policlinico Universitario A. Gemelli IRCCS\u2013Universit\u00e0 Cattolica del Sacro Cuore, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Cauda","sequence":"additional","affiliation":[{"name":"Institute of Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli \u2013 Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)\u2013Universit\u00e0 Cattolica del Sacro Cuore, Rome"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Viale","sequence":"additional","affiliation":[{"name":"Infectious Diseases Unit, Department of Medical and Clinical Sciences, S. Orsola-Malpighi Hospital, Alma Mater Studiorum University of Bologna"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,6,9]]},"reference":[{"key":"key\n\t\t\t\t2019011723581913000_CIT0001","volume-title":"FDA approves new antibacterial drug Avycaz. FDA news release","author":"US Food and Drug Administration (FDA)"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0002","volume-title":"European public assessment report (EPAR) for Zavicefta","author":"European Medicines Agency (EMA)"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0003","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/21505594.2017.1292196","article-title":"Therapeutic options for carbapenem-resistant Enterobacteriaceae infections","volume":"8","author":"Trecarichi","year":"2017","journal-title":"Virulence"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0004","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1586\/14787210.2013.836057","article-title":"Predictors of mortality in multidrug-resistant Klebsiella pneumoniae bloodstream infections","volume":"11","author":"Viale","year":"2013","journal-title":"Expert Rev Anti Infect Ther"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0005","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/CMR.00079-17","article-title":"Treatment of infections caused by extended-spectrum-beta-lactamase-, AmpC-, and carbapenemase-producing Enterobacteriaceae","volume":"31","author":"Rodr\u00edguez-Ba\u00f1o","year":"2018","journal-title":"Clin Microbiol Rev"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0006","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.cmi.2017.08.030","article-title":"Management of KPC-producing Klebsiella pneumoniae infections","volume":"24","author":"Bassetti","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0007","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/1469-0691.12697","article-title":"Treating infections caused by carbapenemase-producing Enterobacteriaceae","volume":"20","author":"Tzouvelekis","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0008","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1093\/cid\/cix893","article-title":"Carbapenemase-producing organisms: a global scourge","volume":"66","author":"Bonomo","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0009","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.2015.12480","article-title":"Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US communities, 2012\u20132013","volume":"314","author":"Guh","year":"2015","journal-title":"JAMA"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0010","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2807\/1560-7917.ES.2015.20.45.30062","article-title":"Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015","volume":"20","author":"Albiger","year":"2015","journal-title":"Euro Surveill"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0011","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1080\/21505594.2016.1222343","article-title":"The global epidemiology of carbapenemase-producing Enterobacteriaceae","volume":"8","author":"van Duin","year":"2017","journal-title":"Virulence"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0012","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1093\/cid\/cis588","article-title":"Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy","volume":"55","author":"Tumbarello","year":"2012","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0013","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/AAC.02373-13","article-title":"Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae","volume":"58","author":"Tumbarello","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0014","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/1469-0691.12747","article-title":"Risk factors for carbapenem-resistant Klebsiella pneumoniae bloodstream infection among rectal carriers: a prospective observational multicentre study","volume":"20","author":"Giannella","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0015","doi-asserted-by":"crossref","first-page":"1106.e1","DOI":"10.1016\/j.cmi.2015.08.001","article-title":"Risk factors for bloodstream infections due to colistin-resistant KPC-producing Klebsiella pneumoniae: results from a multicenter case-control-control study","volume":"21","author":"Giacobbe","year":"2015","journal-title":"Clin Microbiol Infect"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0016","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1093\/cid\/ciw243","article-title":"Ceftazidime\/avibactam and ceftolozane\/tazobactam: second-generation \u03b2-lactam\/\u03b2-lactamase inhibitor combinations","volume":"63","author":"van Duin","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0017","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1473-3099(17)30747-8","article-title":"Ceftazidime-avibactam versus meropenem in nosocomial pneumonia, including ventilator-associated pneumonia (REPROVE): a randomised, double-blind, phase 3 non-inferiority trial","volume":"18","author":"Torres","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0018","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1185\/03007995.2012.748653","article-title":"Efficacy and safety of ceftazidime-avibactam versus imipenem-cilastatin in the treatment of complicated urinary tract infections, including acute pyelonephritis, in hospitalized adults: results of a prospective, investigator-blinded, randomized study","volume":"28","author":"Vazquez","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0019","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/jac\/dks523","article-title":"Comparative study of the efficacy and safety of ceftazidime\/avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infections in hospitalized adults: results of a randomized, double-blind, phase II trial","volume":"68","author":"Lucasti","year":"2013","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0020","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1093\/cid\/ciw133","article-title":"Efficacy and safety of ceftazidime-avibactam plus metronidazole versus meropenem in the treatment of complicated intra-abdominal infection: results from a randomized, controlled, double-blind, phase 3 program","volume":"62","author":"Mazuski","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0021","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1093\/cid\/ciw378","article-title":"Ceftazidime-avibactam versus doripenem for the treatment of complicated urinary tract infections, including acute pyelonephritis: RECAPTURE, a phase 3 randomized trial program","volume":"63","author":"Wagenlehner","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0022","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/AAC.01964-16","article-title":"Ceftazidime-avibactam as salvage therapy for infections caused by carbapenem-resistant organisms","volume":"61","author":"Temkin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0023","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1093\/cid\/ciw636","article-title":"Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections","volume":"63","author":"Shields","year":"2016","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0024","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02497-17","article-title":"Pneumonia and renal replacement therapy are risk factors for ceftazidime-avibactam treatment failures and resistance among patients with carbapenem-resistant Enterobacteriaceae infections","author":"Shields","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0025","doi-asserted-by":"crossref","first-page":"e00449","DOI":"10.1128\/AAC.00449-17","article-title":"Multicenter study of outcomes with ceftazidime-avibactam in patients with carbapenem-resistant Enterobacteriaceae infections","volume":"61","author":"King","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0026","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1128\/AAC.00883-17","article-title":"Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0027","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant Enterobacteriaceae","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0028","doi-asserted-by":"crossref","first-page":"26","DOI":"10.7326\/0003-4819-140-1-200401060-00008","article-title":"International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections","volume":"140","author":"Paterson","year":"2004","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0029","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s00134-017-4683-6","article-title":"Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016","volume":"43","author":"Rhodes","year":"2017","journal-title":"Intensive Care Med"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0030","volume-title":"EUCAST guidelines for detection of resistance mechanisms and specific resistances of clinical and\/or epidemiological importance. Version 2.0, July 2017","author":"European Committee on Antimicrobial Susceptibility Testing (EUCAST)"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0031","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijantimicag.2017.08.019","article-title":"Effect of combination therapy containing a high-dose carbapenem on mortality in patients with carbapenem-resistant Klebsiella pneumoniae bloodstream infection","volume":"51","author":"Giannella","year":"2018","journal-title":"Int J Antimicrob Agents"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0032","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S1473-3099(17)30228-1","article-title":"Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study","volume":"17","author":"Guti\u00e9rrez-Guti\u00e9rrez","year":"2017","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0033","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1128\/AAC.02166-13","article-title":"Carbapenemase-producing Klebsiella pneumoniae bloodstream infections: lowering mortality by antibiotic combination schemes and the role of carbapenems","volume":"58","author":"Daikos","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0034","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1093\/jac\/dkv086","article-title":"Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study","volume":"70","author":"Tumbarello","year":"2015","journal-title":"J Antimicrob Chemother"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0035","volume-title":"Summary of the latest data on antibiotic resistance in EU: 2016","author":"European Centre for Disease Prevention and Control (ECDC)"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0036","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1093\/cid\/ciw805","article-title":"Colistin resistance in carbapenem-resistant Klebsiella pneumoniae: laboratory detection and impact on mortality","volume":"64","author":"Rojas","year":"2017","journal-title":"Clin Infect Dis"},{"key":"key\n\t\t\t\t2019011723581913000_CIT0037","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/jac\/dkm318","article-title":"Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis","volume":"60","author":"Schwaber","year":"2007","journal-title":"J Antimicrob Chemother"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cid\/article-pdf\/68\/3\/355\/27512544\/ciy492.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,5]],"date-time":"2025-07-05T00:43:28Z","timestamp":1751676208000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/68\/3\/355\/5035217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,9]]},"references-count":37,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,6,9]]},"published-print":{"date-parts":[[2019,1,18]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciy492","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"value":"1058-4838","type":"print"},{"value":"1537-6591","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,2,1]]},"published":{"date-parts":[[2018,6,9]]}}}